Table 1 Clinical and biochemical characteristics of the study subjects with or without NAFLD
Variables | Non-NAFLD | NAFLD | P |
|---|---|---|---|
N | 13,581 | 4480 | |
Sex (M/F) | 5191/8390 | 3256/1244 | < 0.001 |
AGE (years) | 39.5 ± 10.5 | 45.8 ± 9.9 | < 0.001 |
BMI (kg/m2) | 22.1 ± 2.6 | 26.4 ± 2.7 | < 0.001 |
SBP (mmHg) | 114.6 ± 14.8 | 127.4 ± 15.7 | < 0.001 |
DBP (mmHg) | 75.4 ± 9.9 | 83.9 ± 10.0 | < 0.001 |
FPG (mM) | 5.2 ± 0.8 | 5.8 ± 1.4 | < 0.001 |
TG (mM) | 1.0 (0.7–1.5) | 2.1 (1.5–3.1) | < 0.001 |
TC (mM) | 4.7 ± 0.9 | 5.2 ± 1.0 | < 0.001 |
LDL-C (mM) | 2.7 ± 0.7 | 3.1 ± 0.8 | < 0.001 |
HDL-C (mM) | 1.5 ± 0.4 | 1.2 ± 0.3 | < 0.001 |
TG/HDL-C | 0.7 (0.4–1.1) | 1.8 (1.2–3.0) | < 0.001 |
SUA (μM) | 302.8 ± 79.6 | 386.2 ± 86.1 | < 0.001 |
Scr (μM) | 70.1 ± 15.3 | 78.1 ± 15.2 | < 0.001 |
ALT (IU/L) | 10 (7–13) | 17 (12–25) | < 0.001 |
AST (IU/L) | 20 (17–24) | 24 (20–30) | < 0.001 |